Prospective validation of the thyroid imaging reporting and data system on thyroid nodules
10.3877/cma.j.issn.1672-6448.2014.02.015
- VernacularTitle:甲状腺影像报告和数据系统在甲状腺结节分类中的前瞻性验证
- Author:
Jing, ZHANG
;
Huixiong, XU
;
Yifeng, ZHANG
;
Junmei, XU
;
Chang, LIU
;
Lehang, GUO
;
Linna, LIU
- Publication Type:Journal Article
- Keywords:
Thyroid nodule;
Ultrasonography;
Thyroid imaging reporting and data system
- From:
Chinese Journal of Medical Ultrasound (Electronic Edition)
2014;(2):167-171
- CountryChina
- Language:Chinese
-
Abstract:
Objective To prospectively validate the feasibility and usefulness of the thyroid imaging reporting and data system (TI-RADS) suggested by Kwak. Methods According to the TI-RADS published in Radiology by Kwak et al in 2011, the TI-RADS score of 810 thyroid nodules in 415 patients whose pathologic diagnoses were available were categorized . According to TI-RADS and pathologic results, receiver operating characteristic (ROC) curve was plotted, and the probability of malignancy in each category was calculated. Results Eight hundred and ten pathologically proven thyroid nodules included 649 benign and 161 malignant lesions. Among them, 11 nodules were categorized as TI-RADS 2 (all benign nodules);370 nodules were categorized as TI-RADS 3 (368 benign nodules and 2 malignant nodules);150 nodules were categorized as TI-RADS 4a (143 benign nodules and 7 malignant nodules);116 nodules were categorized as TI-RADS 4b (87 benign nodules and 29 malignant nodules); 146 nodules were categorized as TI-RADS 4c (39 benign nodules and 107 malignant nodules);17 nodules were categorized as TI-RADS 5 (1 benign nodules and 16 malignant nodules). The area under the curve of TI-RADS was 0.89, and the probability of malignancy in nodules with a classiifcation of TI-RADS 2, 3, 4a, 4b, 4c and 5 was 0, 0.5%, 4.6%, 25.0%, 73.0%and 94.0%, respectively. Conclusions The TI-RADS suggested by Kwak has great diagnostic value in diagnosing thyroid nodules. The actual probability of malignancy conforms with the theoretical risk of malignancy.
